Relay Therapeutics (RLAY)
NASDAQ:RLAY
Relay Therapeutics (RLAY) Ownership Overview
2.33% Insiders
9.29% Mutual Funds
53.23% Other Institutional Investors
12.10% ETFs
23.05% Public Companies and
Individual Investors
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 74.61% of the company’s stock is owned by Institutional Investors, 2.33% is owned by Insiders, and 23.05% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 29, 2026 | xxxxxxxxxxxxx | $119631 | |
Jan 29, 2026 | xxxxxxxxxxxxx | $100473 | |
Jan 29, 2026 | xxxxxxxxxxxxx | $166677 | |
Jan 07, 2026 | xxxxxxxxxxxxx | $337574 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $195645 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $281176 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $5745312 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $16101452 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,925,975 | Institution | 4.43% | 82,113,101 | |
| 6,581,020 | Institution | 3.68% | 68,179,367 | |
| 6,541,084 | Institution | 3.66% | 67,765,630 | |
| 3,578,904 | Institution | 2.00% | 37,077,445 | |
| 1,903,245 | Institution | 1.06% | 19,717,618 | |
| 1,547,944 | Insider | 0.87% | 16,036,700 | |
| 1,506,946 | Institution | 0.84% | 15,611,961 | |
| 1,325,200 | Institution | 0.74% | 13,729,072 | |
| 1,160,117 | Institution | 0.65% | 12,018,812 | |
| 1,104,939 | Institution | 0.62% | 11,447,168 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,581,020 | Institution | 3.68% | 68,179,367 | |
| 1,506,946 | Institution | 0.84% | 15,611,961 | |
| 1,325,200 | Institution | 0.74% | 13,729,072 | |
| 1,104,939 | Institution | 0.62% | 11,447,168 | |
| 1,025,008 | Institution | 0.57% | 10,619,083 | |
| 745,831 | Institution | 0.42% | 7,726,809 | |
| 739,153 | Institution | 0.41% | 7,657,625 | |
| 558,084 | Institution | 0.31% | 5,781,750 | |
| 482,003 | Institution | 0.27% | 4,993,551 | |
| 401,280 | Institution | 0.22% | 4,157,261 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,155,001 | Institution | 2.88% | 39,487,308 | |
| 3,332,835 | Institution | 1.86% | 34,528,171 | |
| 3,296,236 | Institution | 1.84% | 34,775,290 | |
| 1,432,710 | Institution | 0.80% | 10,974,559 | |
| 1,220,093 | Institution | 0.68% | 12,640,163 | |
| 943,140 | Institution | 0.53% | 9,770,930 | |
| 670,359 | Institution | 0.38% | 5,134,950 | |
| 645,711 | Institution | 0.36% | 6,812,251 | |
| 488,504 | Institution | 0.27% | 5,153,717 | |
| 378,364 | Institution | 0.21% | 3,991,740 |
FAQ
Who Owns Relay Therapeutics (RLAY)?
According to the latest TipRanks data, approximately 53.23% of the company's stock is held by institutional investors, 2.33% is held by insiders, and 23.05% is held by retail investors.
What percentage of Relay Therapeutics (RLAY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 53.23% of Relay Therapeutics (RLAY) stock is held by institutional investors.
What percentage of Relay Therapeutics (RLAY) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.05% of Relay Therapeutics (RLAY) stock is held by retail investors.
Who owns the most shares of Relay Therapeutics (RLAY)?
Vanguard owns the most shares of Relay Therapeutics (RLAY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.